Detection of oxidative DNA damage in oesophageal biopsies of patients with reflux symptoms and normal pH monitoring

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 7, 2003, Pages 693-698

  Liu, L ^a   Ergun, G ^a   Ertan, A ^a   Woods, K ^a   Sachs, I ^a   Younes, M ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; ESOPHAGUS BIOPSY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 0142027691     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01734.x     Document Type: Article

References (23)

1. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982; 307; 1547-52.
2. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986; 315: 362-71.
3. Schlesinger PK, Donahue PE, Schmid B, Layden TJ. Limitations of 24-hour intraesophageal pH monitoring in the hospital setting. Gastroenterology 1985; 89: 797-804.
4. Wetscher GJ, Perdikis G, Kretchmar DH, et al. Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 1995; 40: 1297-305.
5. Wetscher GJ, Hinder RA, Bagchi D, et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995; 170: 552-6; discussion 556-7.
6. Wetscher GJ, Hinder RA, Klingler P, Gadenstatter M, Perdikis G, Hinder PR. Reflux esophagitis in humans is a free radical event. Dis Esophagus 1997; 10: 29-32; discussion 33.
7. Carlson N, Lechago J, Richter J, et al. Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation. Am J Gastroenterol 2002; 97: 1340-5.
8. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol 2001; 35: 613-8.
9. Seki S, Kitada T, Yamada T, et al. Immunohistochemical detection of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, in human chronic cholecystitis. Histopathology 2002; 40: 531-5.
10. Otani K, Shimizu S, Chijüwa K, Yamaguchi K, Noshiro H, Tanaka M. Immunohistochemical detection of 8-hydroxy-2′-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction. Eur J Gastroenterol Hepatol 2001; 13: 1363-9.
11. Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-56.
12. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G - T and A - C substitutions. J Biol Chem 1992; 267: 166-72.
13. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′ -deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-63.
14. Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-74.
15. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. J Am Med Assoc 1993; 270: 1320.
16. Hakansson HO, Johnsson F, Johansson J, Kjellen G, Walther B. Development of adenocarcinoma in Barrett's oesophagus after successful antireflux surgery. Eur J Surg 1997; 163: 469-71.
17. Csendes A, Braghetto I, Burdiles P, et al. Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologie, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 1998; 123: 645-57.
18. Csendes A, Burdiles P, Braghetto I, Korn O, Diaz JC, Rojas J. Early and late results of the acid suppression and duodenal diversion operation in patients with Barrett's esophagus: analysis of 210 cases. World J Surg 2002; 26: 566-76.
19. Fitzgerald RC, Lascar R. Triadafilopoulos G. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression. Aliment Pharmacol Ther 2001; 15: 269-76.
20. Gerson LB, Shetler K, Triadafilopoulos G, Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
21. Allgayer H, Kolb M, Stuber V, Kruis W. Effects of bile acids on base hydroxylation in a model of human colonic mucosal DNA. Cancer Detect Prev 2002; 26: 85-9.
22. Matzen LE, Larsen JB, Froland A. Glycosylated hemoglobin A1 used in quality-control of diabetes care: a cross-sectional study in an outpatient clinic. Diabetes Res 1985; 2: 243-7.
23. Mohi-Ud-din R, Williams DC, Maher KA, Evans SRT. Benjamin SB. Evaluation of patients with reflux-like dyspepsia not responsive to medical therapy. Gastrointest Endosc 2003; 57: M1747.